BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 26415590)

  • 1. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
    Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
    J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes.
    Chen MZ; Chang JC; Zavala-Solorio J; Kates L; Thai M; Ogasawara A; Bai X; Flanagan S; Nunez V; Phamluong K; Ziai J; Newman R; Warming S; Kolumam G; Sonoda J
    Mol Metab; 2017 Nov; 6(11):1454-1467. PubMed ID: 29107292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
    Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
    Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brown Adipose YY1 Deficiency Activates Expression of Secreted Proteins Linked to Energy Expenditure and Prevents Diet-Induced Obesity.
    Verdeguer F; Soustek MS; Hatting M; Blättler SM; McDonald D; Barrow JJ; Puigserver P
    Mol Cell Biol; 2015 Oct; 36(1):184-96. PubMed ID: 26503783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of β-klotho determine the thermogenic responsiveness of adipose tissues: involvement of the autocrine action of FGF21.
    Moure R; Cairó M; Morón-Ros S; Quesada-López T; Campderrós L; Cereijo R; Hernáez A; Villarroya F; Giralt M
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E822-E834. PubMed ID: 33615874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.
    Véniant MM; Sivits G; Helmering J; Komorowski R; Lee J; Fan W; Moyer C; Lloyd DJ
    Cell Metab; 2015 May; 21(5):731-8. PubMed ID: 25955208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue.
    Markan KR; Naber MC; Small SM; Peltekian L; Kessler RL; Potthoff MJ
    Mol Metab; 2017 Jun; 6(6):602-610. PubMed ID: 28580290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
    Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
    Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.
    Kwon MM; O'Dwyer SM; Baker RK; Covey SD; Kieffer TJ
    Cell Rep; 2015 Nov; 13(8):1521-7. PubMed ID: 26586424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.
    Hondares E; Gallego-Escuredo JM; Flachs P; Frontini A; Cereijo R; Goday A; Perugini J; Kopecky P; Giralt M; Cinti S; Kopecky J; Villarroya F
    Metabolism; 2014 Mar; 63(3):312-7. PubMed ID: 24369918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism.
    Wanders D; Forney LA; Stone KP; Burk DH; Pierse A; Gettys TW
    Diabetes; 2017 Apr; 66(4):858-867. PubMed ID: 28096260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
    BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
    Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance.
    Szczepańska E; Gietka-Czernel M
    Horm Metab Res; 2022 Apr; 54(4):203-211. PubMed ID: 35413740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.
    Martínez-Garza Ú; Torres-Oteros D; Yarritu-Gallego A; Marrero PF; Haro D; Relat J
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.